1.
According to the article, why are international pharmaceutical giants in
For foreign drug companies, it’s the best market in the world right now. Sales growth for the top eight multinational drug firms in
Deregulation has come in three areas. First, the government has speeded up its review of new drugs. The greatly expanded Pharmaceuticals and Medical Devices Agency (PMDA) has slashed review times since 2008 and increased the number of new drugs it has approved
Second, the pricing system is under review. Previously, the price of new drugs would be lowered every two years. This made it hard to cover the cost of innovation. Soon, the price of new medicines will be maintained through the life of the patent, which would make them more profitable.
Third, the authorities have said that 30% of the volume of drugs sold should be generics, a goal it has almost reached. This has hit smaller Japanese drug firms, but it helps others.
According to the article, why are international pharmaceutical giants in
According to the article, how will the change in the pricing system affect innovation?
Third, the authorities have said that 30% of the volume of drugs sold should be generics, a goal it has almost reached.
The greatly expanded Pharmaceuticals and Medical Devices Agency (PMDA) has slashed review times since 2008 and increased the number of new drugs it has approved.
This means that the review times have been
Based on the information in the article, what will the impact of generics have on small, older, Japanese pharmaceutical companies?
月額1,000円〜 最新のニュース記事で手軽に始めるビジネス英語学習
もっと沢山の記事を読んで学習をしたいなら、Business English Pro 、 1日10分ビジネス英語 の受講がお薦めです!
Business English Pro と 1日10分ビジネス英語なら記事は週5日間、最新のニュースを使った学習記事が毎日配信されます。
さらに Business English Proなら